Asian Spectator

Times Advertising

World's First FDA IDE Coronary Patient Treated With a DEB

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
NYON, Switzerland, July 11, 2020 /PRNewswire-AsiaNet/ -- MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR(TM) 014 DEB (http://medalliance.com/product/ )for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthroug...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...

Jerat algoritma: AI perburuk beban ganda ojol dan kurir perempuan di Indonesia

● Sistem AI mengeksploitasi tenaga kerja informal melalui ekstraksi data dan pengalihan risiko kepada mereka.● Algoritma merugikan perempuan karena mengabaikan realitas beban domestik, isu...

Narasi “kebangkitan batu bara” bermunculan efek perang Iran, tapi data menunjukkan fakta sebaliknya

● Di tengah krisis energi global, data menunjukkan penggunaan batu bara dan gas justru turun, sementara energi terbarukan meningkat.● Tren penurunan ekspor baru bara di Indonesia sudah ter...